HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. He added that he looks forward to working with the team on realizing this great mission. formerly ModeRNA Therapeutics, was founded in 2011 and primarily focuses on developing mRNA vaccines. The Moderna Success Story. Moderna Inc.,

CFO 52

CFO Chief Financial Officer Due Diligence Biotechnology 52

Harvard Business Review

SEPTEMBER 14, 2011

In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Suzlon's head of technology is John O'Halloran, a former Cummins Engine executive who now leads Suzlon's 500-strong global R&D team out of Hamburg. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 16, 2016

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. In 2011, he commissioned a report that called for an “innovation policy” rather than an “industrial policy.” The Era of Big Science. Often, that information is considered proprietary.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 19, 2015

“If others have flexibility for personal reasons” — say they coach their daughter’s soccer team, they take guitar lessons, or they are writing a book — “you may be able to have flexibility to pursue a vocational passion, too.” “I knew I wanted to be free to make these big decisions.”

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22